Medroxyprogesterone Acetate EP Impurity C

It is one of impurity present in Medroxyprogesterone, Medroxyprogesterone acetate inhibits the production of gonadotropin, preventing follicular maturation and ovulation, which is responsible for its ability to prevent pregnancy. This action also thins the endometrium. MPA reduces nuclear estrogen receptors and DNA synthesis in epithelial cells of the endometrium, also induces p53 dependant apoptosis in certain cancer cell lines, and inhibits GABA-A receptors, which reduces nuclear estrogen receptors and DNA synthesis in epithelial cells of the endometrium and induces p53 dependant apoptosis in cancer cell lines, Medroxyprogesterone Acetate used as a contraceptive and in the treatment of secondary amenorrhea, abnormal uterine bleeding.

Additional information on Medroxyprogesterone Acetate EP Impurity C

Catalogue No.

VE007806

CAS No.

N/A

Molecular Formula

C24H34O4

Molecular Weight

386.52 g/mol

Parent drug

Medroxyprogesterone

IUPAC Name

6α, 17a-Dimethyl-3, 17-dioxo-D-homoandrost-4-en-17aα-yl acetate

Synonyms

N/A

References

Sathe, A., & Gerriets, V. (2022, May 19). Medroxyprogesterone. Retrieved November 4, 2022, from Nih.gov website: https://www.ncbi.nlm.nih.gov/books/NBK559192/

Status

In-stock